• kickyvanleeuwen
• May 2, 2024
• • News
• • mediaire
  • mr
  • mdprostate
  • prostate cancer

mediaire has launched the new version of mdprostate, which now includes the capability for longitudinal evaluation of prostate lesions. The results of previous examinations are automatically compared and provided in a tabular view enabling the assessment of the volumetric changes of the lesion. Additionally, the performance of the tool has been improved according to mediaire.

Link to official press release.